Skye Bioscience, Inc. SKYE
Set alert
1.28 USD -0.02 -1.54%
At close · Oct 30
1.28 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
1.28 Day range 1.42
1.28 52-week range 12.40
- YTD
- -78.67%
- 1 year
- -89.12%
- Open
- 1.37
- Prev close
- 1.30
- Mkt cap
- 5.67M
- Vol
- 40.56K
- Avg vol
- 90.42K
- EPS
- -10.16
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.28
- High
- 1.42
- Forward P/E
- -2.27
- Beta
- 1.75
- Short ratio
- 10.06
- Inst. own
- 86.03%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 29, 2024
- 50-d avg
- 4.44
- 200-d avg
- 7.74
- 1y target
- 18.00
Financial health
Altman Z-Score
-41.53 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 4
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -0.5×
FY 2016 5y median -0.5× FY 2025
P/S 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 1.5×
FY 2016 5y median 1.5× FY 2025
P/FCF -0.7×
FY 2016 5y median -1.4× FY 2025
EV/EBITDA -0.4×
FY 2016 5y median -0.6× FY 2025
EV/Sales 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -144.8%
FY 2016 5y median -73.3% FY 2025
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -279.3%
FY 2016 5y median -39.0% FY 2025
ROIC -286.6%
FY 2016 5y median -98.1% FY 2025
ROA -197.5%
FY 2016 5y median -197.5% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2025
Operating Income -92.6%
FY 2016 FY 2025
EPS (diluted) -93.2%
FY 2016 FY 2025
Free Cash Flow -60.5%
FY 2016 FY 2025
Financial Health
Current Ratio 3.3×
FY 2016 5y median 2.5× FY 2025
Quick Ratio 3.3×
FY 2016 5y median 2.5× FY 2025
Debt / Equity 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.1×
FY 2016 5y median 0.1× FY 2025
Interest Coverage 0.0×
FY 2016 5y median -27.6× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31